The Consortium of Multiple Sclerosis Centers (CMSC) is teaming up with the Foundation of the CMSC and EMD Serono to launch a new Mental Health Mini Mentorship Program this summer.
The Consortium of Multiple Sclerosis Centers (CMSC) is teaming up with the Foundation of the CMSC and EMD Serono to launch a new Mental Health Mini Mentorship Program this summer. The week-long program is designed to educate clinicians who have expressed interest in the unique mental challenges faced by the estimated 1 million people in the United States living with MS.
The program will be offered 4 times throughout the summer at Holy Name Medical Center’s MS Center in Teaneck, New Jersey, and at the Multiple Sclerosis Center at Hackensack University Medical Center (HUMC) in Hackensack, New Jersey.
“We are excited to bring the MS Mental Health Mini-Mentorship program to life at Holy Name and HUMC this summer,” said June Halper, chief executive officer of CMSC. “This program was conceived to address a vitally important challenge faced by multiple sclerosis patients: lack of adequate recognition and treatment of their mental health-related symptoms, which are just as important as the physical obstacles they face.”
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Distinguishing Biomarkers Identified in MS Outcomes
March 19th 2024Results from this cohort study found that levels of glial fibrillary acid protein, cerebral spinal fluid, and neurofilament heavy chain are distinguishable biomarkers that are associated with disease outcomes in multiple sclerosis (MS).
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Navigating the Mental Health Challenges of Cancer Diagnosis, Treatment, and Survivorship
March 12th 2024Stress has potential links to worse outcomes in cancer, such as decreased quality of life and greater risks of disease progression and metastasis. There is a complex mix of emotions patients with cancer experience.
Read More
FDA Issues CRL for Glatiramer Acetate Depot for Relapsing Forms of MS
March 11th 2024The FDA has declined to approve glatiramer acetate (GA) depot in the treatment of relapsing types of multiple sclerosis (MS), issuing a complete response letter (CRL) for the long-acting, injectable form of GA.
Read More